Sign In

Alan Sage

CEO/President at Vaporox Inc.

Alan Sage is the CEO and President of Vaporox Inc., a company focused on commercializing Vaporous Hyperoxia Therapy (VHT™) for treating chronic wounds.12 He has extensive experience in entrepreneurship and business leadership:

Professional Background

  • Founded and led multiple startups, including Digabit Inc. (2010-2017) and Aftama Inc. (2008-2010)1
  • Co-founded Configuresoft, which was acquired by EMC/VMware1
  • Served as Interim President/COO at Bell ATM Service, Inc. (2018)1
  • Executive Consultant at Sage Partners since 20071

Expertise

  • Specializes in helping entrepreneurs fund, build, and sell companies1
  • Experienced in SaaS, software development, IT, technology, asset management, e-commerce, and manufacturing1
  • Skilled in raising capital, organizational growth, product management, and sales strategies1

Education

  • Attended Colorado State University (1986-1991)1
  • Completed personal development curriculum at Landmark (1993-2016)1

Current Role at Vaporox

As CEO and President, Alan Sage leads Vaporox in developing and commercializing VHT technology, which is FDA-510K-cleared for treating various skin wounds, including diabetic foot ulcers and pressure ulcers.12

Highlights

Vaporox Company Spotlight - HMP Global Learning Network
Vaporox Company Spotlight - SmartTRAK Blog
Vaporox Company Spotlight - SmartTRAK Blog

Related Questions

What is Vaporous Hyperoxia Therapy (VHT™)?
How did Alan Sage's experience at Digabit influence his leadership at Vaporox?
What are the main challenges Alan Sage has faced as CEO of Vaporox?
How does Vaporox's technology compare to other wound treatments?
What is the significance of the FDA-510K clearance for Vaporox's technology?
Alan Sage
Alan Sage, photo 1
Alan Sage, photo 2
Add to my network

Location

Denver, Colorado, United States